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Abstract 
Background: Various supra-molecular structures form by self-assembly of proteins in a symmetric fashion. Examples 
of such structures are viruses, some bacterial micro-compartments and eukaryotic vaults. Peptide/protein-based 
nanoparticles are emerging in synthetic biology for a variety of biomedical applications, mainly as drug targeting and 
delivery systems or as vaccines. Our self-assembling peptide nanoparticles (SAPNs) are formed by a single peptide 
chain that consists of two helical coiled-coil segments connected by a short linker region. One helix is forming a pen-
tameric coiled coil while the other is forming a trimeric coiled coil.
Results: Here, we were studying in vitro and in silico the effect of the chain length and of point mutations near the 
linker region between the pentamer and the trimer on the self-assembly of the SAPNs. 60 identical peptide chains co-
assemble to form a spherical nanoparticle displaying icosahedral symmetry. We have stepwise reduced the size of the 
protein chain to a minimal chain length of 36 amino acids. We first used biochemical and biophysical methods on the 
longer constructs followed by molecular dynamics simulations to study eleven different smaller peptide constructs. 
We have identified one peptide that shows the most promising mini-nanoparticle model in silico.
Conclusions: An approach of in silico modeling combined with in vitro testing and verification yielded promising 
peptide designs: at a minimal chain length of only 36 amino acids they were able to self-assemble into proper nano-
particles. This is important since the production cost increases more than linearly with chain length. Also the size of 
the nanoparticles is significantly smaller than 20 nm, thus reducing the immunogenicity of the particles, which in turn 
may allow to use the SAPNs as drug delivery systems without the risk of an anaphylactic shock.
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Background
Proteins of varied structures have evolved in nature to 
self-assemble into spherical nanoparticles. Examples of 
such supra-molecular structures are viruses [1], some 
bacterial micro-compartments [2] or eukaryotic vaults 
[3], which form by self-assembly of folded proteins in 
a symmetric fashion. They often perform sophisticated 
cellular functions. Such nanoparticles have a central cav-
ity that can be exploited as a simple encapsulation sys-
tem for the transport and controlled release and delivery 
of drugs and genes to targeted cells [4–6]. They can also 
be used in protein separation, enzyme immobilization, 
and in blood cell substitution [7, 8]. Virus-like particles 
have long been used as vaccine platforms for infectious 
diseases but they could potentially also be used as thera-
peutic vaccines to treat addiction and other diseases 
such as cancer [9, 10]. In our group we are designing 
self-assembling peptide nanoparticles (SAPNs) as vac-
cines for infectious diseases like malaria [11], HIV [12] 
or influenza [13], but they can be used for many other 
diseases [14].
Our SAPNs are formed by a single peptide chain that 
consists of two helical coiled-coil segments connected by 
a short linker region. One helix is forming a pentameric 
coiled coil while the other is forming a trimeric coiled coil 
(Fig.  1a, b). Coiled coils are an ubiquitous protein fold-
ing and oligomerization motif that exhibits abundance 
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in sequence and function [15]. For instance, coiled coils 
like bZIP transcription factors contain a DNA-binding 
sequence whereas other coiled coils like intermediate 
filaments and spectrin can be structural components of 
the cell [16]. Furthermore, coiled coils can have dynamic 
functions such as myosin and dyneins, which act as 
“movement” proteins [16]. The majority of α-helical 
coiled coils are based on a heptad sequence repeat, com-
posed of seven amino acids usually denoted abcdefg 
[17]. From two to seven strands of α-helices wrap around 
each other to create a superhelical twist that is normally 
left-handed [15]. The driving force for the interaction 
between these α-helices are the hydrophobic amino acids 
located in positions a and d of the heptad repeat. Ionic 
interactions between residues, for example in position e 
and g of the heptad repeat (i to i + 5) in parallel dimers 
and trimers, also further stabilize coiled-coil interfaces.
Coiled coil stability can further be influenced by a num-
ber of factors including helical propensity of the residues, 
helix dipole, helix capping effects, translational and rota-
tional entropy contributions and length of the coiled coil 
[15]. Litowski et al. investigated the effect of chain length 
in their heterodimeric coiled-coil system used in appli-
cations such as biosensors and affinity chromatography. 
Their study showed that an increase in chain length led 
to an increase in stability of heterodimeric coiled coils, 
however, the effect was nonlinear [18].
In a departure from studies of chain length effects, 
we have previously aimed to design the shortest pos-
sible coiled coil peptide using principles that play a part 
in monomeric α-helical stability or oligomeric packing. 
Interestingly, a two heptad-repeat peptide was produced 
that was 100 % dimeric under physiological buffer condi-
tions [19, 20].
Here we have further investigated the influence of 
the length of the coiled coil for the self-assembly of 
our SAPNs, notably the length of the de novo designed 
trimer. There are many factors that govern the self-
assembly of the peptide nanoparticles such as the nature 
of the linker region, constitution of pentamer and trimer. 
In a first step we decided to investigate the effect of the 
trimer length on the self-assembly of the SAPNs. Apart 
from inherent scientific curiosity, useful applications 
of this study would be potential chemical syntheses of 
Fig. 1 Amino acid sequence and three-dimensional model of peptide building block, pentamer-trimer complex, and mini-nanoparticle. a Amino 
acid sequence from the tryptophan zipper [PDB:1T8Z] and a de novo designed trimeric coiled-coil peptide [PDB:1HQJ] aligned with the sequence 
of the channel-forming domain of colicin E1 [PDB:2I88]. A parent sequence T2I88 is shown below that has been followed to build the initial model 
of the mini-nanoparticle peptide. Computational model of the starting construct (peptide 1) (b), neighboring pentamer-trimer complex (c), and a 
mini-nanoparticle (d) were built using the initial model of the peptide
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the monomeric polypeptide instead of production with 
recombinant protein technology. Chemically synthesiz-
ing a long polypeptide is expensive, hence a shorter poly-
peptide displaying the same properties would be very 
advantageous and it would also allow for easier chemical 
functionalization.
Three constructs were designed, expressed, purified 
and refolded under different buffer compositions (Figs. 2 
and   3). It was found that even with only 2.5 heptad 
repeats in the trimer peptide nanoparticles were formed. 
Furthermore, pH and salt concentration were shown to 
greatly affect the size and aggregation state of the SAPNs.
Apart from the length of the coiled coils designing 
and optimizing the correct linker has a pivotal role in 
the development of a nanoparticle that correctly refolds 
in vitro. We have done an exhaustive search in the pro-
tein data bank to find a template for a helix-turn-helix 
motif in which the angle between the two helices is about 
38°, corresponding to the angle between the fivefold and 
threefold axes in an icosahedron. Our recent study [21] 
has shown that such a motif of the crystal structure of 
colicin E1 [PDB:2I88] gives the optimum template for the 
linker (Fig. 1a), which can covalently connect two neigh-
boring helices to produce correctly folded nanoparticles. 
In a second step we try to further optimize this linker 
region by the use of molecular dynamics simulations of 
the small peptide.
All these different mutants along with the initial par-
ent peptide (Fig. 3) were studied by molecular dynamics 
(MD) simulations using the program CHARMM 36b1 in 
an attempt to further optimize the linker region and find 
the best peptide building block for the SAPNs.
Results
Biophysical analysis
From the linker constitution study it was found that a 
malaria nanoparticle vaccine construct self-assembled 
into almost spherical nanoparticles [21]. The de novo 
trimeric coiled coil in this construct had 6.5 heptad 
repeats (46 residues). This led us to the question: if the 
trimeric coiled coil was shortened would nanoparticles 
still be formed? To answer this question the original 
Fig. 2 Monomeric building block and computer models of complete SAPNs. Top: monomeric building block composed of a His-tag sequence 
(black), a pentameric domain based on Trp-zipper (green) and a shortened trimeric de novo designed coiled-coil domain (blue). Bottom Computer 
models of the complete peptide nanoparticle with a diameter of roughly 21 nm. The black region (His-tag) is a random coil, which could be fully 
extended giving a diameter of roughly 27 nm. a 2HR, b 2.5HR and c 3HR
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construct was genetically engineered by PCR-mediated 
site-directed mutagenesis to create three new constructs. 
Their sequences can be found in Fig.  3 and molecular 
models of the three designs are shown in Fig. 2.
The SDS-PAGE gel for 3HR showed that this construct 
expressed well. Elution from the Ni-affinity column took 
place at pH 4.5 and also in a buffer containing 250 mM 
imidazole. The predicted molecular weight for 3HR is 
10,251.3 Da.
Stepwise refolding at pH 7.0 and pH 8.0 was attempted 
but resulted in aggregation. Direct refolding at pH 10.5 
(20  mM CAPSO, 450  mM NaCl, 5  % glycerol) resulted 
in nanoparticles as can be observed from TEM and DLS 
(Fig. 4a, Additional file 1: Figure S1). However, it is evi-
dent from both, the DLS and the TEM data, that the 
preparation is significantly heterogeneous.
The SDS-PAGE gel for 2.5HR showed a similar pattern 
to 3HR except there also seemed to be elution at pH 5.2. 
The predicted molecular weight for 2.5HR is 9805.7 Da.
The first refolding scheme attempted for 2.5HR was 
direct refolding (dialysis against a buffer with no urea). 
Direct refolding at pH 10.5 (20  mM CAPSO, 50  mM 
NaCl, 5  % glycerol) resulted in nanoparticles as can 
be observed from TEM and DLS but also aggregation 
(Fig. 4b; Additional file 1: Figure S1).
To further characterize 2.5HR a pH screening was per-
formed. Briefly, the quick refolding method, where the 
protein is concentrated to 1 mg/ml then diluted 20 times 
to a buffer with no urea, was used. For the buffers used 
for dilution the salt concentration (50  mM NaCl) and 
glycerol volumes (5 %) were kept constant, only varying 
the buffering agent for each pH (pH 7.5–20 mM Hepes, 
pH 8.5–20 mM Tris, pH 9.5–20 mM CAPSO). At pH 7.5 
precipitation in the dialysis bag was observed. At pH 8.5 
there seemed to be no aggregation visible to the naked 
eye. However, investigation by TEM revealed clusters of 
aggregation. Only at pH 9.5 were there very nice nano-
particles visible (Fig. 4c).
We decided to further screen different salt concentra-
tions at this pH to confirm nanoparticle assembly. The 
quick refolding method described above was used. The 
different buffers had the same pH 9.5 (20 mM CAPSO) 
and same glycerol concentration (5 %) only the salt con-
centration varied: no salt, 50  mM NaCl, 100  mM NaCl 
and 400  mM NaCl. It seems that as the salt concentra-
tion is increased the nanoparticle diameter also increases 
(Additional file 2: Figure S2).
The construct with the shortest trimer was 2HR. 
Elution from the Ni-affinity column occurred largely 
at pH 5.2 but also at pH 6.3 and at pH 5.9. However, 
direct refolding at pH 10.5 (20  mM CAPSO, 50  mM 
NaCl, 5  % glycerol) resulted in aggregation. Refolding 
of 2HR under pHs 9.5 and 8.5 also resulted in aggrega-





Molecular Dynamics Study ChargeOverall Pentamer Trimer
parent$
a  d   a  d   a    d   a  d   a  d  
1-DWQAWKDDWAYWTLTWKYGELYSKLAELERRLEELA-36
1 DWQAWKEEWAYWTLTWKYGELYSKLAELERRLEELR -2 -1 -1
2 DWQAWKEEWAYWTLTWKYGELYTKLAELERRLEELR -2 -1 -1
3 DWQAWKEEWAYWTLCWKYGELYCKLAELERRLEELR -2 -1 -1
4 DWQAWKEEWAYWTLTWKYGELYNKLAELERRLEELR -2 -1 -1
5 DWQAWKAEWAYWTLTWKYGELYTKLAELERRLEELR -1 0 -1
6 DWQAWKAEWAYWTLCWKYGELYCKLAELERRLEELR -1 0 -1
7 DWQAWKEEWAYWTLTWKYGELYTKLAELEERLEELR -4 -1 -3
8 DWQAWKEEWAYWTLCWKYGELYCKLAELEERLEELR -4 -1 -3
9 DWQAWKAEWAYWTLTWKYGELYSKLAELERRLEELR -1 0 -1
10 DWQAWKEEWAYWTLTWKYGELYSKLAELEERLEELR -4 -1 -3
11 DWQAWKREWAYWTLTWKYGELYSKLADLERRLEELR 0 +1 -1
$ Sequence from the peptide in Doll et al., 2015 [21]
Fig. 3 Amino acid sequences of the designed constructs used for biophysical and molecular dynamics simulation study
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it wasn’t evaluated by DLS or TEM so results were not 
included.
SAPN was settled less than 24 h for DLS measurement 
and the suspension was not diluted. For accuracy pur-
poses five scans were collected. The goal of this study was 
to characterize SAPNs immediately after refolding and 
long term stability was not evaluated. Previous research 
efforts in our group shows that both long term settling 
of SAPNs and their concentration might or might not 
affect the morphology of SAPNs. It depends upon pro-
tein sequence, storage temperature and buffer [22].
Molecular dynamics simulation
Based on our construct design and the biophysical results 
of the 2.5HR we ran a series of molecular dynamics simu-
lations on the eleven short versions of 2.5HR including 
only five helical turns (i.e. 2.5 heptad repeats) around the 
linker region of the nanoparticle peptide (Figs. 3, 5a) in 
an attempt to further optimize the sequence that would 
yield the best refolding behavior. The angle between the 
pentameric and trimeric helices, the overall charge, the 
charge distribution along the peptide chain, and the dif-
ferent non-covalent interactions within the peptide nan-
oparticle, along with the solvent condition, are the key 
parameters that govern the quality of the nanoparticle 
formed in solution. Figure  3 represents different muta-
tions of the parent sequence of the model peptide that we 
have studied by molecular dynamics simulation. Muta-
tions have been introduced close to the glycine residue of 
the linker region of all the constructs. A disulfide bond 
has been introduced by double mutations T15C and 
S23C in peptide 3, peptide 6, and peptide 8 to see how 
this constraint affects the peptide conformation. A sin-
gle mutation S23T on the trimeric side has been intro-
duced in peptide 2, peptide 5, and peptide 7 to see how 
this bulkier residue (threonine versus serine) can affect 
the overall conformation of these peptides. Another sin-
gle mutation S23N on the trimeric side has been tested 
in peptide 4. Additional mutations have been introduced 
a little farther away from the linker region to modify the 
long range electrostatic interactions between the oli-
gomerization domains along the fivefold and threefold 
axes of the icosahedron. Figure  5a represents the 3D 
models of all the initial peptides 1 to 11 with the mutant 
residues in red color. The overall charge in both the pen-
tameric and trimeric domains along with the overall 
charge of the construct are depicted in Fig. 3.
Simulating a complete nanoparticle with spherical 
water around it is very time-consuming as the whole 
solvated system contains about half a million variables 
(Fig.  6b). In contrast, using only an asymmetric unit of 
the icosahedron during molecular dynamics runs and 
simulating the rest of the particle by the icosahedral sym-
metry operations applied to the asymmetric unit, the sys-
tem becomes computationally much more efficient. An 
asymmetric unit can be built by cutting the whole system 
along the four planes passing through the rotational axes 
fivefold and twofold, twofold and threefold, threefold 
and twofold, and twofold and fivefold (Fig. 6a). The side 
and top views of such a wedge-shaped asymmetric unit 
containing only one nanoparticle peptide, water, and ions 
are shown in Fig. 6c, d. During MD simulations only the 
interactions within this wedge and its symmetry-related 
neighbors are calculated, which makes the MD runs 
feasible.
The resulting peptide structures after a 2 ns MD sim-
ulation have been superposed on their corresponding 
initial models (Fig.  5b). Variations of RMSD with time 
of simulation have been calculated in 100  mM sodium 
chloride solution (Fig. 7a) for the eleven models chosen 
initially. Another structural characteristics is the radius 
of gyration (RGYR), which is a combined measure of its 
overall size and shape.
Here, we have calculated the RGYR in 100  mM salt 
environment, which are plotted in Fig.  7b. Panels a and 
b show two clusters of molecules in the salt environment, 
Fig. 4 Electron micrograph of SAPNs with different chain length. a Electron micrograph of 3HR at pH 10.5, b Electron micrograph of 2.5HR at pH 
10.5, and c Electron micrograph of 2.5HR at pH 9.5
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Fig. 6 Building asymmetric unit for molecular dynamics simulation of nanoparticle. a An icosahedron showing twofold, threefold and fivefold axes. 
b A fully solvated nanoparticle in presence of salt ions. Side view (c), and top view (d) of the asymmetric unit of an entirely solvated nanoparticle in 
presence of salt ions
Fig. 5 Initial models and their deviations from corresponding final models after 2 ns of molecular dynamics simulation. a Initial models of 11 con-
structs, where peptides 2 to 11 have been built by in silico mutation on the starting model (peptide 1). Mutations have been indicated by arrows. b 
Nanoparticle peptides of the 11 constructs (shown in magenta color) after 2 ns of molecular dynamics simulation superposed on their correspond-
ing initial peptides (shown in green color)
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one with a diverging tendency (peptides 1, 3, and 4) and 
the other eight constructs (peptides 2, 5, 6, 7, 8, 9, 10, and 
11) with a converging tendency. Eight converging pep-
tides show the variation of RMSD within 7 Å with respect 
to the energy minimized structure, whereas the variation 
of RMSD for the three diverging structures is about 10 Å. 
Again, Fig.  7b shows that the RGYR are pretty stable 
with simulation time, and the value (16.2 Å) for the con-
verging cluster is lower than that of the diverging clus-
ter (18 Å). MD simulations have also been run in water 
environment (data not shown) showing a tendency of 
divergence indicating unstable conformation even after 
2  ns. Thus, adding salt has an important role in folding 
and converging to a stable nanoparticle. Figure 7c shows 
the superposition of 3 diverging constructs (peptides 1, 
3, and 4) after 2 ns of MD simulation. Peptides 1 and 3 
show deformation at the linker region, while peptide 4 
shows deformation at the N-terminus of the pentameric 
helix. In both models, where the linker region contains 
either a disulfide bond between two cysteine residues 
(peptide 3) or a hydrogen bond between threonine and 
asparagine (peptide 4), a deformation of the helices can 
be observed. Similarly, an unbalanced situation in the 
start model (peptide 1) results in a structural deforma-
tion as well (Fig. 7c). The upper clusters in Fig. 7a, b that 
shows the divergence behavior of three model peptides 
(peptides 1, 3, and 4) during 2  ns molecular dynamics 
simulation in presence of 100 mM NaCl, were discarded 
for further analysis. Figure 7d shows the superposition of 
the remaining eight constructs (peptides 2, 5, 6, 7, 8, 9, 
10, and 11), which are converging during 2 ns MD simu-
lation in presence of 100 mM NaCl as shown in the lower 
clusters of the Fig. 7a, b.
Fig. 7 Molecular dynamics simulation of 11 peptides for 2 ns. RMS deviations (a) and radius of gyrations (b) of 11 peptides relative to their cor-
responding energy minimized structures after 2 ns of MD simulation. c Superposition of 3 diverging peptides 1, 3, and 4. d Superposition of 8 
converging peptides 2, 5, 6, 7, 8, 9, 10, and 11
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Additional file  3: Figure  S3 shows the effect of addi-
tional mutation on peptide 2, while Additional file  4: 
Figure  S4 shows the effect of an additional mutation 
on peptide 3. In the model of peptide 2 (with an overall 
charge of −2), where the serine residue in the trimeric 
domain was replaced by threonine (S23T), no defor-
mation of the helices was observed during a 2  ns MD 
simulation. Rather, it converged into a stable helical con-
formation. Although peptide 2 converged to a reasonably 
good structure at the end of MD simulation, when sup-
plemented with an additional mutation (E7A or R30E) 
(peptides 5 and 7), it showed some degree of deforma-
tion in the 3D structure and also a deviation in rmsd and 
radii of gyration (Additional file 3: Figure S3). Specifically, 
in peptide 7, where the mutation R30E causes a loss of 
salt bridge interaction between E7 and R30 in peptide 2, 
a deformation developed at the N-terminus of the pen-
tameric helix (Additional file  3: Figure  S3d). Although 
peptide 2 and peptide 5 did not show much structural 
deformation during 2  ns MD simulation, the angles 
between the pentamer and trimer helices are 49.9° and 
45.7° respectively, which deviate by 12.5° and 8.3° from 
the angle (37.4°) between the corresponding fivefold 
and threefold axes in an icosahedron (Fig. 4a). The angle 
between the two helices in peptide 7 is 34.3°, which is 3.1° 
smaller than the value in the icosahedron. Final models 
of peptides 9 and 10 after 2 ns MD simulation are shown 
in Fig. 5. Alanine substitution in place of Glu7 causes a 
deformation at the N-terminus of the pentameric helix 
in peptide 9. However, the reduced electrostatic interac-
tion caused by the R30E mutation in the trimeric helix of 
peptide 10 results in maintaining the overall conforma-
tion with a slight bending at the C-terminus of this helix 
(Fig. 5b). The double mutation E7R/E27D introduced in 
peptide 11 (Fig.  5b) causes a deformation in the trim-
eric helix while maintaining the helical conformation of 
the pentameric domain. The mutation E7R on the pen-
tameric domain probably repels R30 on the trimeric 
side, thereby initiating both intra- and inter-domain salt 
bridge interactions R30 to D27 and R7 to E34 respec-
tively that lead to a distinct conformational change at the 
C-terminus of the trimeric helix in peptide 11.
By carefully analyzing the 8 converging models in 3D, 
we were able to identify the two peptide models (peptide 
6 and 8) showing lower rmsd and radii of gyrations with 
a reasonable angle between the trimer and pentamer 
while maintaining helical conformations as their sec-
ondary structure. Finally, these two models, peptides 6 
and 8, were selected based on the nature of convergence 
(Additional file 4: Figure 5a, b) and in silico visualization 
on which we further performed MD simulations for a 
longer period of 10 ns (Fig. 8). Interestingly, the peptide 3 
model that shows deformation in MD simulation because 
of the disulfide bond at the linker region, adopts an ade-
quate helical conformation when supplemented with the 
same additional mutation E7A or R30E (peptides 6 and 8) 
beyond the linker region as that studied in peptides 5 and 
7 respectively.
The best model has been selected based on a 10  ns 
MD simulation on these two peptides 6 and 8 (Fig. 8). In 
Fig. 8a, peptide 8 shows a slightly lower RMSD than that 
observed in peptide 6 during the first 6.5 ns simulation. 
Slightly lower radius of gyration for peptide 8 (Fig.  8b) 
also indicating more compactness than peptide 6. The 
angle between the pentameric helix and the trimeric 
helix of our spherical nanoparticle can be greater than 
the theoretical value 37.4° (calculated between the five-
fold and the threefold axes in an icosahedron) depending 
on the flexibility of the linker region. Here, in peptides 6 
and 8 these inter-helical angles are 42.5° and 38.8°. While, 
the minimum value 37.4° corresponds to the perfect 
alignment of pentameric and trimeric helices along the 
fivefold and threefold axes of the icosahedron respec-
tively, the coiled coil add additional twisting to those heli-
cal axes. Analyzing all these observations, we concluded 
that peptide 8 is much closer to an asymmetric unit of 
an ideal T1 icosahedron and considered to be the best 
model out of all 11 constructs.
Discussion
The purpose of this study was to investigate the effect 
of trimer length on the self-assembly of peptide nano-
particles. Given that original malaria construct [21] 
formed nice nanoparticles this construct was selected 
to have its trimer shortened and the epitope removed. 
The strategy used was to engineer a stop codon by PCR-
mediated site-directed mutagenesis at specific locations 
in the trimer resulting in three different lengths (3, 2.5 
and 2) of the heptad repeats in the trimer. Just before 
the stop codon an arginine residue was introduced so 
as to further stabilize the short trimeric coiled coil. The 
hypothesis was that the arginine’s positive charge would 
counteract the negative charge of the carboxy termi-
nus and make the coiled-coil interaction as strong as 
possible.
It is clear from the results with all three designs the 
crucial role pH plays in the self-assembly of the SAPNs. 
The monomeric peptide consists of a fusion protein 
where the pentameric coiled coil is connected by a short 
linker to the trimeric coiled coil. Because of icosahe-
dral symmetry the pentamer and trimer are at an angle 
where residues close to the linker region from the pen-
tamer can interact with residues from the trimer. If the 
overall charge in the pentamer is the same as the overall 
charge in the trimer then they will repel each other. On 
the other hand, if the pentamer and trimer have opposite 
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overall charges then they will attract each other (see 
Fig. 3).
Another interesting effect is salt concentration on 
nanoparticle size (Additional file 2: Figure S2). For 2.5HR 
it seems that as the concentration of NaCl is increased, 
larger nanoparticles are obtained.
Given that the trimer length for SAPNs to self-assem-
ble are 3 and 2.5 heptad repeats, the next logical step was 
to investigate if self-assembly occurs with a shorter pen-
tamer. How short can you make the pentamer and trimer 
and still get nanoparticle assembly? To assess the feasi-
bility of future lab work on such minimized peptides, we 
have performed molecular dynamics studies. Our obser-
vation on peptide-based mininanoparticles based on 
molecular dynamics simulations elucidated the depend-
encies of point mutations close to and nearby the linker 
region on the assembly of simulated nanoparticles. Flex-
ibility in the linker region induced by a G19 can be con-
trolled by the design and optimization of a single/double 
mutation near the linker region. We also studied the 
effect on the nanoparticle assembly of some point muta-
tions further away from the linker region. A molecular 
dynamics simulation of 11 designed constructs showed 
the variation of convergence into helical conforma-
tion of the two oligomerization domains as well as that 
of the inter-helical angle. Peptide 8 folded into the best-
assembled nanoparticle after 10  ns molecular dynamics 
simulation. In this construct we incorporated a disulfide 
bond by double mutations T15C and S23C together with 
a third point mutation A30E in the trimeric domain. 
Although the disulfide bond alone (peptide 3) distorted 
the peptide conformation, when the additional mutation 
Fig. 8 Molecular dynamics simulation of two peptides 6 and 8 for 10 ns. RMS deviations (a) and radius of gyrations (b) of the two peptides 6 and 8 
relative to their corresponding energy minimized structures after 10 ns of MD simulation. Side view (c) and top view (d) of the superposition of the 
molecular structure of peptide 6 (in red color) on peptide 8 (in green color) after 10 ns of MD simulation
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R30E was included (peptide 8), it converged into a well-
folded nanoparticle.
This computational study on peptide mini-SAPNs 
could potentially benefit the nanotechnology of thera-
peutic development, especially in vaccine design, drug 
delivery, and bio-imaging. If you could get a so-called 
“mini nanoparticle” chemical peptide syntheses might 
be useful to manufacture the peptide instead of rely-
ing on recombinant production with E. coli. For vaccine 
research chemical syntheses of peptide nanoparticles 
would be advantageous, as traditional contaminants 
inherent to protein purification such as LPS and pro-
teases would be eliminated. This in turn would allow 
the peptide nanoparticle to be on “fast-track” to Phase I 
clinical trials and major hurdles with the FDA could be 
avoided. For example Audran et  al. have led a synthetic 
peptide derived from a Malaria antigen into a phase I 
Malaria vaccine trial [23].
Conclusions
Our investigation demonstrated that the protein con-
formation is dependent on point mutations within and 
nearby the linker region to allow proper self-assembly of 
the SAPNs. Flexibility in the linker region induced by gly-
cine residues is needed to allow for the helix-turn-helix 
motif, but on the other hand the protein chain can be 
stabilized in this conformation by the choice of optimal 
neighboring residues. We studied the effect of point muta-
tions within and somewhat more distant from the linker 
region on the nanoparticle assembly. A molecular dynam-
ics simulation of 11 designed peptide constructs showed 
the variation of convergence into a helical conformation 
of the two oligomerization domains and a stabilization of 
the angle between the two coiled-coil domains. Peptide 8 
folded into the best-assembled nanoparticle after a 10 ns 
molecular dynamics simulation. Engineering a disulfide 
bond into the linker region to stabilize the relative orienta-
tion of the pentamer and the trimer distorted the peptide 
conformation. But when combining a third mutation with 
the disulfide bond it converged into a well-folded nanopar-
ticle. In conclusion, the particular amino acid sequences of 
the linker region has a significant effect on the assembly 
properties of the SAPNs. Combining mutations within the 
linker itself with mutations more distant from the linker 
can provide a powerful way to design and optimize its pep-
tide sequence. This computational and biophysical study 
may allow the engineering of devices that can be used for 
drug targeting, drug delivery, and bio-imaging.
Methods
Cloning
In order to introduce an arginine followed by a stop 
codon in T2i88-8-pf [21] site-directed mutagenesis PCR 
was used. The resulting plasmids were transformed into 
Escherichia Coli strain DH5α by heat shock. The result-
ing ampicilin-resistant colonies were screened for the 
recombinant gene by sequencing after miniprep (Pro-
mega, Madison, WI, USA). Plasmids harboring the 
desired genes were transformed into the Escherichia Coli 
strain BL21(DE3) expression cells (Novagen, Gibbstown, 
NJ, USA) and a 20  % glycerol stock of each construct 
(3HR, 2.5HR and 2HR) was stored at −80 °C.
Protein expression
An overnight culture (50  ml) of BL21(DE3) (Novagen, 
Gibbstown, NJ, USA) cells containing the expression 
construct was added to LB (3L) supplemented with ampi-
cillin (Fisher, Pittsburgh, PA, USA, 6 ml, 100 mg/ml). The 
culture was incubated (190 rpm, 37 °C) until the OD600 
reached ~0.5–0.6, at which time protein expression was 
induced (IPTG, Fisher, Pittsburgh, PA, USA, 3 ml, 1 M) 
and the culture incubated further (190 rpm, 37 °C, 3 h). 
The cells were isolated by centrifugation (4000g, 12 min), 
and the pellet was stored at −80 °C.
Protein purification
Purification was done under denaturing conditions (9  M 
urea). Cell pellet was thawed on ice, resuspended in 
lysis buffer A which is composed of 9  M Urea, 100  mM 
NaH2PO4, 10 mM Tris and 10 mM β-mercaptoethanol, pH 
8.0 and lysed by sonication (SONICATOR → 3000 Ultra-
sonic Liquid Processor, cycle of 4 s pulse at 55 % amplitude 
followed by a 6 s rest repeated for a 10 min period). The 
insoluble cell debris was cleared by centrifugation (45 min 
at 30,500g). The supernatant was then incubated with 
nickel beads (Qiagen, Valencia, CA, USA) for one hour. 
Possible DNA contamination was removed by a wash 
with buffer B at pH 8.0: 9  M Urea, 500  mM NaH2PO4, 
10  mM Tris, 10  mM imidazole. Protein contaminants 
were washed from the column using a pH gradient and 
10 mM imidazole in the buffers. The first wash was done 
with lysis buffer A and the second and third washes at 
pHs 6.3 and 5.9 respectively with a buffer containing 9 M 
Urea, 100 mM NaH2PO4, 20 mM sodium citrate, 10 mM 
imidazole and 10  mM β- mercaptoethanol. Elution was 
done at pH 5.2 and pH 4.5 again with 9 M Urea, 100 mM 
NaH2PO4, 20 mM sodium citrate, 10 mM imidazole and 
10 mM β-mercaptoethanol. Any protein that did not elute 
at the lower pH washes was eluted with buffers contain-
ing high concentration of imidazole (buffer C: 9 M Urea, 
100 mM NaH2PO4, 10 mM Tris, 250 mM imidazole, pH 
8.0 or buffer D: 9 M Urea, 100 mM NaH2PO4, 10 mM Tris, 
500 mM imidazole, pH 8.0).
Protein purity was verified by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (15  % gel). Follow-
ing purification, the denatured monomeric peptides 
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were refolded using one of the following three methods: 
(1) dialysis performed in a stepwise manner (stepwise 
refolding) (2) one step dialysis against a buffer with no 
urea (direct refolding) or (3) concentrated (Amicon Ultra 
centrifugal filter devices, Millipore, Billerica, MA, USA) 
and diluted to a buffer with no urea (quick refolding). The 
proteins were filtered with a 0.1 μm polyvinylidene fluo-
ride membrane filter before and after dialysis (Millipore, 
Billerica, MA, USA, #SLVV 033 RS).
For all three designs (3HR, 2.5HR and 2HR) the protein 
concentration was calculated using the absorbance at 
280  nm with the extinction coefficient (M−1  cm−1) and 
molecular weight (Daltons) of the protein. The extinc-
tion coefficient and molecular weight were obtained with 
ExPASy’s ProtParam tool (http://ca.expasy.org/tools/
protparam.html).
Dynamic light scattering
The hydrodynamic diameter was obtained with a Mal-
vern Zetasizer Nano S equipped with a 633  nm laser 
using a 3 mm path length quartz suprasil cell. The meas-
urements were done at 25  °C and for each protein five 
scans were collected.
Transmission electron microscopy
Transmission Electron Microscopy samples were nega-
tively stained with 1  % uranyl acetate (SPI) at a pep-
tide concentration of 50  μg/ml. Electron micrographs 
were taken with a Philips EM 300 transmission elec-
tron microscope at an accelerating voltage of 80 kV. The 
micrographs were scanned at 600 dpi.
Model building
A starting model of the nanoparticle peptide was built 
using the crystal structures of the helix-turn-helix motif of 
the channel-forming domain of colicin E1 [24], the trypto-
phan zipper [25] and a de novo designed trimeric coiled-
coil peptide [26] as templates for the linker, the N-terminal 
pentameric domain and the C-terminal trimeric domain, 
respectively (Fig. 1a). The model building (Fig. 1b) was done 
in silico using the graphics program ‘O’ version 12.0.1 [27].
Molecular dynamics simulation
Eleven different constructs were studied by molecular 
dynamics (MD) simulations with CHARMM 36b1 [28] 
installed on a Linux cluster at the Biotech Center of the 
University of Connecticut. The whole MD simulation 
procedure is divided into five steps: vacuum minimiza-
tion, solvation, energy minimization, heating and equili-
bration, and production dynamics. The peptide molecule 
was solvated and ions were added to achieve a particular 
salt concentration. In the energy minimization step, we 
used the steepest descent (SD) method for 50 steps fol-
lowed by the adopted basis Newton–Raphson (ABNR) 
method for 50,000 steps, where each step is 1  fs. After 
the energy minimization of the whole system, the tem-
perature was raised slowly to 300 K from an initial tem-
perature of 100 K at a rate of 10°/1000 steps to relax the 
molecule and then to run the equilibration for a total 
time of 100 ps, including the time to raise the tempera-
ture. Production dynamics for 2  ns were run thereafter 
on the whole system for initial screening. Long 10  ns 
production dynamics were also performed on selected 
models to find the best one. To analyze the final models, 
we have calculated root mean square deviation (RMSD) 
and radius of gyration (RGYR) with respect to the energy 
minimized structure using CHARMM algorithm [28].
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Additional files
Additional file 1. Figure S1. Dynamic light scattering experiment of SAPNs 
with different monomeric chain length. (a) Dynamic light scattering 
of 3HR at pH 10.5. The DLS graph of 3HR shows some heterogeneity 
composed of nanoparticles (average diameter = 23.3 nm) and some 
aggregation. (b) Dynamic light scattering of 2.5HR at pH 9.5. The DLS 
graph of 2.5HR shows a single peak (average diameter = 23.4 nm) and no 
aggregation.
Additional file 2. Figure S2. Transmission electron micrographs of 2.5HR at 
pH 9.5 (20 mM CAPSO) and different NaCl concentrations. (a) 0 mM, (b) 50 
mM, (c) 100 mM and (d) 400 mM.
Additional file 3. Figure S3. Molecular dynamics simulation of three 
peptides 2, 5, and 7 for 2 ns. RMS deviations (a) and radius of gyrations (b) 
of the three peptides 2, 5, and 7 relative to their corresponding energy 
minimized structures after 2 ns of MD simulation. (c) Superposition of the 
molecular structure of peptide 5 on peptide 2 after 2 ns of MD simulation. 
(d) Superposition of the molecular structure of peptide 7 on peptide 2 
after 2 ns of MD simulation.
Additional file 4. Figure S4. Molecular dynamics simulation of three 
peptides 3, 6, and 8 for 2 ns. RMS deviations (a) and radius of gyrations (b) 
of the three peptides 3, 6, and 8 relative to their corresponding energy 
minimized structures after 2 ns of MD simulation. (c) Superposition of the 
molecular structure of peptide 6 on peptide 3 after 2 ns of MD simulation. 
(d) Superposition of the molecular structure of peptide 8 on peptide 3 
after 2 ns of MD simulation.
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